Oncolysin-B immunoconjugate: Began Phase I/II trial

ImmunoGen Inc. (IMGN), Cambridge, Mass. Product: Oncolysin-B immunoconjugate, consisting of blocked ricin linked to a monoclonal antibody, to eliminate multidrug resistance in tumors Indication: Relap...